Role of lipid rafts in activation-induced cell death: The Fas pathway in aging

Advances in Experimental Medicine and Biology

Volumn 584, Issue , 2006, Pages 137-155

  Larbi, Anis ^a   Muti, Elisa ^b   Giacconi, Roberta ^b   Mocchegiani, Eugenio ^b   Fülöp, Tamàs ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b INRCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934443378     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-34132-3_11     Document Type: Conference Paper

References (95)

1. S.W. Hetts, To die or not to die: an overview of apoptosis and its role in disease, JAMA. 279, 300-307 (1998).
2. D. Kabelitz, and O. Janssen, Antigen-induced death of T-lymphocytes. Front Biosci. 2, d61-77 (1997).
3. O. Janssen, R. Sanzenbacher, and D. Kabelitz, Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell Tissue Res. 301, 85-99 (2000).
4. A. Oehm, I. Behrman, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B.C. Trauth, H. Ponsting, and P.H. Krammer, Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem. 267, 10709-10715 (1992).
5. S. Nagata, and P. Golstein, The Fas death factor. Science. 267, 1449-1456 (1995).
6. K. Simons, and E. Ikonen, Functional rafts in cell membranes. Nature. 387, 569-572 (1997).
7. D. Scheel-Toellner, K. Wang, R. Singh, S. Majeed, K. Raza, S.J. Curnow, M. Salmon, and J.M. Lord, The death-inducing signalling complex is recruited to lipid rafts in Fas-induced apoptosis. Biochem Biophys Res Commun. 297, 876-879 (2002).
8. A. Larbi, N. Douziech, G. Dupuis, A. Khalil, H. Pelletier, K.P. Guérard, and T. Fulop, Age-associated alterations in the recruitment of signal-transduction proteins to lipid rafts in human T lymphocytes. J Leukoc Biol. 75, 373-381 (2004).
9. T. Fulop, A. Larbi, G. Dupuis, and G. Pawelec, Ageing, autoimmunity and arthritis: Perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune system. Arthritis Res Ther. 5, 290-302 (2003).
10. A.H. Wyllie, What is apoptosis. Histopathology. 10, 995-998 (1986).
11. I.N. Crispe, Death and destruction of activated T lymphocytes. Immunol Res. 19, 143-157 (1999).
12. A.H. Wyllie, R.G. Morris, A.L. Smith, and D.J. Dunlop, Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis J Pathol. 142, 67-77 (1984).
13. J. Yang, X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, T.I. Peng, D.P. Jones, and X. Wang, Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275, 1129-1132 (1997).
14. M. Castedo, T. Hirsch, S.A. Susin, N. Zamzani, P. Marchetti, A. Macho, and G.J. Kroeger, Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis J Immunol. 157, 512-521 (1996).
15. A. Walker, C. Ward, E.L. Taylor, I. Dransfield, S.P. Hart, C. Haslett, and A.G. Rossi, Regulation of neutrophil apoptosis and removal of apoptotic cells. Curr Drug Targets Inflamm Allergy. 4, 447-454 (2005).
16. L.L. Carter, X. Zhang, C. Dubey, P. Rogers, L. Tsui, and S.L. Swain, Regulation of T cell subsets from naive to memory. J Immunother. 21, 181-187 (1998).
17. A.E. Nel, T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J Allergy Clin Immunol. 109, 758-770 (2002).
18. S.G. Maher, C.E. Condron, D.J. Bouchier-Hayes, and D.M. Toomey, Taurine attenuates CD3/interleukin-2-induced T cell apoptosis in an in vitro model of activationinduced cell death (AICD). Clin Exp Immunol. 139, 279-286 (2005).
19. P.H. Krammer, CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol. 71, 163-210 (1997).
20. P. Golstein, Cell death: TRAIL and its receptors. Curr Biol. 7, R750-753 (1997).
21. V. Depraetere, and P. Golstein, Fas and other cell death signaling pathways. Semin Immunol. 9, 93-107 (1997).
22. H. Loetscher, Y.C. Pan, H.W. Lahm, R. Gentz, M. Brockhaus, H. Tabuchi, and W. Lesskauer, Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell. 61, 351-359 (1990).
23. N. Itoh, S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata, The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66, 233-243 (1991).
24. S. Nagata, Apoptosis by death factor. Cell. 88, 355-365 (1997).
25. L.A. Tartaglia, T.M. Ayres, G.H. Wong, and D.V. Goeddel, A novel domain within the 55 kd. TNF receptor signals cell death. Cell. 74, 845-853 (1993).
26. G. Pan, J. Ni, Y.F. Wei, G. Yu, R. Gentz, and V.M. Dixit, An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science. 277, 815-818 (1997).
27. R.N. Kolesnick, A. Haimovitz-Friedman, and Z. Fuks, The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem Cell Biol. 72, 471-474 (1994).
28. W. Stoffel, Functional analysis of acid and neutral sphingomyelinases in vitro and in vivo. Chem Phys Lipids. 102, 107-121 (1999).
29. A. Lahm, A. Paradisi, D.R. Green, and G. Melino, Death fold domain interaction in apoptosis. Cell Death Differ. 10, 10-12 (2003).
30. S.W. Lee, Y.G. Ko, S. Bang, K.S. Kim, and S. Kim, Death effector domain of a mammalian apoptosis mediator, FADD, induces bacterial cell death. Mol Microbiol. 35, 1540-1549 (2000).
31. T. Van den Berghe, G. van Loo, X. Saelens, M. van Gurp, G. Brouckaert, M. Kalai, W. Declerq, and P.J. Vandenabeele, Differential signaling to apoptotic and necrotic cell death by Fas-associated death domain protein FADD. J. Biol Chem. 279, 7925-7933 (2004).
32. J.P. Medema, R.E. Toes, C. Scaffidi, T.S. Zheng, R.A. Flavell, C.J. Melief, M.E. Peter, R. Offringa, and P.H. Krammer, Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis. Eur J Immunol. 27, 3492-3498 (1997).
33. H. Hirata, A. Takahashi, S. Kobayashi, S. Yonehara, H. Sawai, T. Okazaki, K. Yamamoto, and M. Sasada, Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med. 187, 587-600 (1998).
34. N. Yasuda, K. Gotoh, S. Minatoguchi, K. Asano, K. Nishigaki, M. Nomura, A. Ohno, M. Watanabe, H. Sano, H. Kumada, T. Sawa, and H. Fujiwara, An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. Respir Med. 92, 993-999 (1998).
35. G. Melzani, G. Bugari, G. Parrinello, G. Mori, A.M. Manganoni, and G. De Panfilis, Evaluation of soluble Fas ligand as a serological marker for melanoma. Dermatology. 205, 111-115 (2002).
36. F. Silvestris, D. Grinello, M. Tucci, P. Cafforio, and F. Dammacco, Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus. Lupus 12, 8-14 (2003).
37. M. Tanaka, T. Itai, M. Adachi, and S. Nagata, Downregulation of Fas ligand by shedding. Nat Med. 4, 31-36 (1998).
38. V. Screpanti, R.P. Wallin, H.G. Ljunggren, and A.J. Grandien, A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. J Immunol. 167, 2068-2073 (2001).
39. D. Cefai, R. Schwaninger, M. Balli, T. Brunner, and C.D. Gimmi, Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapy. Cell Death Differ. 8, 687-695 (2001).
40. J. Dhein, H. Walczak, C. Baumler, K.M. Debatin, and P.H. Krammer, Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 373, 438-441 (1995).
41. T. Brunner, R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, W.R. Force, D.H. Lynch, C.F. Ware, and D.R. Green, Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas Nature. 373, 441-444 (1995).
42. T.Y. Wang, R. Leventis, and J.R. Silvius, Fluorescence-based evaluation of the partitioning of lipids and lipidated peptides into liquid-ordered lipid microdomains: a model for molecular partitioning into "lipid rafts". Biophys J. 79, 919-933 (2000).
43. V. Horejsi, The roles of membrane microdomains (rafts) in T cell activation. Immunol Rev. 191:148-164 (2003).
44. V. Horejsi, Lipid rafts and their roles in T-cell activation. Microbes Infect. 7:310-316 (2005).
45. A. Viola, S. Schroeder, Y. Sakakibara, and A. Lanzavecchia, T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science. 283, 680-682 (1999).
46. A. Lanzavecchia, G. Lezzi, and A. Viola, From TCR engagement to T cell activation: a kinetic view of T cell behaviour. Cell. 9, 1-4 (1999).
47. 2+ signaling in T-lymphocytes. Crit. Rev. Immunol. 18, 419-448 (1998).
48. S.F. Walk, M.E. March, and K.S. Ravichandran, Roles of Lck, Syk and ZAP-70 tyrosine kinases in TCR-mediated phosphorylation of the adapter protein Shc. Eur. J. Immunol. 28, 2265-2275 (1998).
49. R. Bosselut, W.G. Zhang, J.M. Ashe, J.L. Kopacz, L.E. Samelson, and A. Singer, Association of the adaptor molecule LAT with CD4 and CD8 coreceptors identifies a new coreceptor function in T cell receptor signal transduction. J. Exp. Med. 190, 1517-1526 (1999).
50. L.P. Kane, J. Lin, and A. Weiss, Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 12, 242-249 (2000).
51. A.D. Wells, H. Gudmundsdottir, and L.A. Turka, Following the fate of individuals T cells throughout activation and clonal expansion - signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative reponse. J. Clin. Invest. 100, 3173-3183 (1997).
52. P. Drevot, C. Langlet, X.J. Guo, A.M. Bernard, O. Colard, J.P. Chauvin, R. Laserre, and H.T. He, TCR signal initiation machinery is pre-assembled and activated in a subset of membrane rafts. EMBO J. 21, 1899-1909 (2002).
53. L. Bini, S. Pacini, S. Liberatore, S. Valensin, M. Pellegrini, R. Raggiaschi, V. Pallini, and C.T. Baldari, Extensive temporally regulated reorganization of the lipid raft proteome following T cell antigen receptor triggering. Biochem. J. 369, 301-309 (2003).
54. J.A. Rotolo, J. Zhang, M. Donepudi, H. Lee, Z. Fuks, and R.J. Kolesnick, Caspase-dependent and -independent activation of acid sphingomyelinase signaling. J Biol Chem. 280, 26425-26434 (2005).
55. H. Grassme, A. Jekle, A. Riehle, H. Schwrz, J. Berger, K. Sandhoff, R. Kolesnick, and E.J. Gulbins, CD95 signaling via ceramide-rich membrane rafts. J Biol Chem. 276, 20589-20596 (2001).
56. Y. Lavie, and M. Liscovitch, Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences. Glycoconj J. 17, 253-259 (2000).
57. V. Ayllon, A. Fleischer, X. Cayla, A. Garcia, and A.J. Rebollo, Segregation of Bad from lipid rafts is implicated in the induction of apoptosis. J Immunol. 168, 3387-3393 (2002).
58. L.A. O'Reilly, U. Divisekera, K. Newton, K. Scalzo, T. Kataoka, H. Puthalakath, M. Ito, D.C. Huang, and A. Strasser, Modifications and intracellular trafficking of FADD/MORT1 and caspase-8 after stimulation of T lymphocytes. Cell Death Differ. 11, 724-736 (2004).
59. D.F. Legler, O. Micheau, M.A. Doucey, J. Tschopp, and C. Bron, Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity. 18, 655-664 (2003).
60. D. Delmas, C. Rebe, O. Micheau, A. Athias, P. Gambert, S. Grazide, G. Laurent, N. Latruffe, and E. Solary, Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene. 23, 8979-8986 (2004).
61. D. Delmas, C. Rebe, S. Lacour, R. Filomenko, A. Athias, P. Gambert, M. Cherkaoui-Malki, B. Jannin, L. Dubrez-Daloz, N. Latruffe, and E.J. Solary, Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells J Biol Chem. 278, 41482-41490 (2003).
62. J.R. Muppidi, and R.M. Siegel, Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat Immunol. 5, 182-189 (2004).
63. S.M. Aouad, L.Y. Cohen, E. Sharif-Askari, E.K. Haddad, A. Alam, and R.P. Sekaly, Caspase-3 is a component of Fas death-inducing signaling complex in lipid rafts and its activity is required for complete caspase-8 activation during Fas-mediated cell death. J Immunol. 172, 2316-2323 (2004).
64. A. Garcia, X. Cayla, A. Fleischer, J. Guergnon, F. Alvarez-Franco Canas, M.P. Rebollo, F. Roncal, and A. Rebollo, Rafts: a simple way to control apoptosis by subcellular redistribution. Biochimie. 85, 727-731 (2003).
65. A. Larbi, N. Douziech, A. Khalil, G. Dupuis, S. Gherairi, K.P. Guerard, and T. Fulop, Effects of methyl-beta-cyclodextrin on T lymphocytes lipid rafts with aging. Exp Gerontol. 39, 551-558 (2004).
66. R. Gniadecki, Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis. Biochem Biophys Res Commun. 320, 165-169 (2004).
67. J.R. Muppidi, J. Tschopp, and R.M. Siegel, Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction Immunity. 21, 461-465 (2004).
68. D. Scheel-Toellner, K. Wang, L.K. Assi, P.R. Webb, R.M. Craddock, M. Salmon, and J.M. Lord, Clustering of death receptors in lipid rafts initiates neutrophil spontaneous apoptosis. Biochem Soc Trans. 32, 679-681 (2004).
69. C. Gajate, and F.J. Mollinedo, Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy. J Biol Chem. 280, 11641-11647 (2005).
70. F. Henkler, E. Behrle, K.M. Bennehy, A. Wicovsky, N. Peters, C. Warnke, K. Pfizenmaier, and H. Wajant, The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability. J Cell Biol. 168, 1087-1098 (2005).
71. T. Fulop, A. Larbi, A. Wikby, E. Mocchegiani, K. Hirokawa, and G. Pawelec, Dysregulation of T-cell function in the elderly : scientific basis and clinical implications. Drugs Aging. 22, 589-603 (2005).
72. A. Larbi, N. Douziech, C. Fortin, A. Linteau, G. Dupuis, and T. Fulop, The role of the MAPK pathway alterations in GM-CSF modulated human neutrophil apoptosis with aging. Immun Ageing. 2, 6 (2005) .
73. C.R. Gomez, E.D. Boehmer, and E.J. Kovacs, The aging innate immune system. Curr Opin Immunol. 17, 457-462 (2005).
74. R. Solana, and E. Mariani, NK and NK/T cells in human senescence. Vaccine. 18, 1613-1620 (2000).
75. D.D. Taub, and D.L. Longo, Insights into thymic aging and regeneration. Immunol Rev. 205, 72-93 (2005).
76. L. Ginaldi, M. De Martinis, D. Monti, and C. Franceschi, The immune system in the elderly: activation-induced and damage-induced apoptosis. Immunol Res. 30, 81-94 (2004).
77. J. Pido-Lopez, N. Imami, D. Andrew, and R. Aspinall, Molecular quantitation of thymic output in mice and the effect of IL-7. Eur J Immunol. 32, 2827-2836 (2002).
78. J.M. Lord, A.N. Akbar, and D. Kipling, Telomere-based therapy for immunosenescence. Trends Immunol. 23, 175-176 (2002).
79. C. Franceschi, S. Valensin, F. Fagnoni, C. Barbi, and M. Bonafe, Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load. Exp Gerontol. 34, 911-912 (1999).
80. N. Douziech, I. Seres, A. Larbi, E. Szikszay, P.M. Roy, M. Arcand, G., Dupuis, and T. Fulop, Modulation of human lymphocyte proliferative response with aging. Exp Gerontol. 37, 369-387 (2002).
81. G. Pawelec, A. Akbar, C. Caruso, R. Solana, B. Grubeck-Loebenstein, and A. Wikby, Human immunosenescence: is it infectious? Immunol Rev. 205, 257-268 (2005).
82. G. Pawelec, K. Hirokawa, and T. Fulop, Altered T cell signalling in ageing. Mech Ageing Dev. 122, 1613-1637 (2001).
83. G.G. Garcia, and R.A. Miller, Single-cell analyses reveal two defects in peptidespecific activation of naive T cells from aged mice. J Immunol. 166, 3151-3157 (2001).
84. G.G. Garcia, S.B. Berger, A.A. Sadighi Akha, and R.A. Miller, Age-associated changes in glycosylation of CD43 and CD45 on mouse CD4 T cells. Eur J Immunol. 35, 622-631 (2005).
85. J.J. Goronzy, and C.M. Weyand, Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther. 5, 225-234 (2003).
86. S. Gupta, H. Su, R. Bi, S. Aggarwal, and S. Gollapudi, Life and death of lymphocytes: a role in immunesenescence. Immun Ageing. 2, 12 (2005).
87. S. Aggarwal, and S. Gupta, Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J Immunol. 160, 1627-1637 (1998).
88. S. Gupta, Molecular and biochemical pathways of apoptosis in lymphocytes from aged humans. Vaccine. 18, 1596-1601 (2000).
89. S. Aggarwal, and S. Gupta, Increased activity of caspase 3 and caspase 8 in anti-Fas-induced apoptosis in lymphocytes from ageing humans. Clin Exp Immunol. 117, 285-290 (1999).
90. C. Spaulding, W. Guo, and R.B. Effros, Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp Gerontol. 34, 633-644 (1999).
91. M.A. Phelouzat, A. Arbogast, T. Laforge, R.A. Quadri, and J.J. Proust, Excessive apoptosis of mature T lymphocytes is a characteristic feature of human immune senescence. Mech Ageing Dev. 88, 25-38 (1996).
92. D. Monti, S. Salvioli, M. Capri, W. Malorni, E. Straface, A. Cossarizza, B. Botti, M. Piacentini, G. Baggio, C. Barbi, S. Valensin, M. Bonafe, and C. Franceschi, Decreased susceptibility to oxidative stress-induced apoptosis of peripheral blood mononuclear cells from healthy elderly and centenarians. Mech Ageing Dev. 121, 239-250 (2000).
93. G. Pawelec, Y. Barnett, R. Forsey, D. Frasca, A. Globerson, J. McLeod, C. Caruso, C. Franceschi, T. Fulop, S. Gupta, E. Mariani, E. Mocchegiani, and R. Solana, T cells and aging, January 2002 update Front Biosci. 7, d1056-1183 (2002).
94. H.C. Hsu, J. Shi, P. Yang, X. Xu, C. Dodd, Y. Matsuki, H.G. Zhang, and J.D. Mountz, Activated CD8(+) T cells from aged mice exhibit decreased activation-induced cell death. Mech Ageing Dev. 122, 1663-1684 (2001).
95. T. Yokoyama, J. Du, Y. Kawamoto, H. Suzuki, and I. Nakashima, Inhibition of Fasmediated apoptotic cell death of murine T lymphocytes in a mouse model of immunosenescence in linkage to deterioration in cell membrane raft function. Immunology. 112, 64-71 (2004).